Capital raised by life sciences companies in California by quarter 2022-2023

Published by
Matej Mikulic,
Dec 10, 2024
In the third quarter of 2023, Californian life sciences companies raised over 18 billion dollars of capital, in the form of IPOs, corporate M&As, venture capital, and private equity. This statistic describes the capital raised by life sciences companies in California from Q4 2022 to Q3 2023.

Capital raised by life sciences companies in California from Q4 2022 to Q3 2023 (in million U.S. dollars)

Loading statistic...

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2024

Region

United States (California)

Survey time period

Q4 2022 to Q3 2023

Supplementary notes

Capital raised includes IPOs, corporate M&As, venture capital, and private equity.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Global unicorns "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Global unicorns

Global overview

8

Key markets

8

Equity funding

5

Exits

8

Further Content: You might find this interesting as well

Topics

Life sciences hub CaliforniaBiotech drugsResearch and development worldwidePharmaceutical research and development (R&D)Pharmaceutical and biotech M&A activities
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.